Catalyst Fund IPOs sixth company

By SETH FREEDMAN
April 25, 2006 07:46

Catalyst bought it shares in Omrix for $1.6 million in February 2005. The fund is currently finishing the closing of its follow-on fund, Catalyst II.




Catalyst Fund said Omrix Biopharmaceuticals, one of its portfolio companies, will be brought to market in an IPO, marking the sixth exit for Catalyst from companies it has acquired. Catalyst bought it shares in Omrix for $1.6 million in February 2005. The fund is currently finishing the closing of its follow-on fund, Catalyst II.


Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS

Israel Weather
  • 8 - 18
    Beer Sheva
    12 - 18
    Tel Aviv - Yafo
  • 7 - 13
    Jerusalem
    11 - 16
    Haifa
  • 12 - 22
    Elat
    11 - 18
    Tiberias